ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Miss Nina: She has heart disease

Patient basic information Patient: Ms. Nina Miller) Nationality: Equatorial Guinea Diagnosis: Cardiomyopathy Diagnostic Hospital: M. O.

O. O. Treatment: Targeted Treatment + Immunotherapy Accommodation: 62 days Treatment cost: approximately 167733 yuan Treatment effect: Functional recovery Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process.

The MD2 team used a comprehensive set of targeted therapeutic+immunotherapies, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs during the treatment process. After 62 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, the test indicators returned to normal areas and successfully reached the standard of hospitalization. Treatment results The patient's final functional recovery.

When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track the recovery through the remote follow-up system. 'Ladies and gentlemen, this case has been criticized by experts as a typical case of cross-border suspected seriousness in clinical cases. The multi-disciplinary collaborative mechanism for the development of targeted therapeutic+immunotherapy programs for cardiomyopathy reflects the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and is a shorthand for the regulation of the international delivery of medical services.

赤道几内亚,心肌病,天津医科大学总医院,国际医疗,来华就医,中国医疗